
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Fowler, Cardiologist in Stanford, CA?
Dr. Michael Fowler is a Cardiologist, who primarily practices in Stanford, CA. Dr. Fowler graduated from Charing Cross & Westminster Medical Schools. Dr. Fowler is fluent in English and Spanish, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Fowler’s office at (650) 723-6459.
Where did Dr. Fowler go to medical school and complete their residency?
Medical School: Charing Cross & Westminster Medical Schools | St. George's University of London
What languages does Dr. Fowler speak?
Dr. Fowler and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Cardiologist like Dr. Fowler typically treat?
As a Cardiologist, Dr. Fowler diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Fowler. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Chronic Systolic Heart Failure
- Heart Failure
- Long-term Systolic Heart Failure
- Chronic HFrEF
- Ongoing Pumping Heart Failure
- Congestive Heart Failure
- CHF
- Cardiac Insufficiency
ICD-10 Codes:
- I5022: Chronic systolic (congestive) heart failure
- I509: Heart failure, unspecified
Also known as:
- Implantable Defibrillator Management
- Pacemakers and Implantable Defibrillators
- AICD Management
- Defibrillator Adjustment
- ICD Care
ICD-10 Codes:
- Z4502: Encounter for adjustment and management of automatic implantable cardiac defibrillator
Also known as:
- Having an Implantable Cardiac Defibrillator (ICD)
- Pacemakers and Implantable Defibrillators
- ICD implant
- Automatic defibrillator
- Implanted heart shock device
ICD-10 Codes:
- Z95810: Presence of automatic (implantable) cardiac defibrillator
Also known as:
- Cardiomyopathy
- Heart Muscle Disease
- Enlarged Heart
ICD-10 Codes:
- I429: Cardiomyopathy, unspecified
What procedures does a Cardiologist like Dr. Fowler typically perform?
As a Cardiologist, procedures performed by Dr. Michael Fowler may include:
- Absent Pulmonary Valve Repair
- Anomalous Coronary Artery Angiography
- Anticoagulation Management
- Aortic Stenosis Repair
- Aortic Valve Repair / Replacement
- Aortopulmonary Window Repair
- Arterial Doppler
- Balloon Septostomy
Please contact Dr. Fowler's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Fowler accept my insurance?
Dr. Fowler accepts most major insurance plans. Important: Please call our office at (650) 723-6459 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Fowler accept in Stanford, CA?
Dr. Fowler in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Centene Corporation
View All Insurances
Where is Dr. Fowler's office located?
What hospitals are Dr. Fowler affiliated with?
Castle Connolly Top Hospital
This doctor is affiliated with a Castle Connolly Top Hospital.
Dr. Fowler has admitting privileges at the following hospitals:
Recognitions
Publications
Dipeptidyl Peptidase 4 Inhibition Increases Myocardial Glucose Uptake in Nonischemic Cardiomyopathy
, 2012
Chemotherapy-Associated Cardiotoxicity: How Often Does it Really Occur and How Can it Be Prevented?
, 2011
Measurement Precision in the Optimization of Cardiac Resynchronization Therapy
, 2010
Dyssynchrony Assessment with Tissue Doppler Imaging
, 2010
Worsening of Left Ventricular End-Systolic Volume
, 2009
Hypertension, heart failure, and beta-adrenergic blocking drugs
, 2008
Insulin-resistant cardiomyopathy
, 2008
Impact of nesiritide on rel function in patients with acute decompensated failure an pre
, 2007
Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness
, 2007
beta-blocker dosing in community-based treatment of heart failure
, 2007
Why do we need to prevent right ventricular pacing?
, 2007
The effect of gender on mortality or appropriate shock
, 2007
Emerging therapies for the magement of decompensated heart failure - From bench to bedside
, 2006
Cardiomyopathy of insulin resistance.
, 2006
Care magement for low-risk patients with heart failure - A randomized, controlled trial
, 2004
Insulin resistance in idiopathic dilated cardiomyopathy - A possible etiologic link
, 2004
Carvedilol prospective randomized cumulative survival (COPERNICUS) trial
, 2004
Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction
, 2003
Neurohormol and clinical responses to high- versus low
, 2002
Beta-adrenergic blocking drugs in severe heart failure.
, 2002
Influence of carvedilol on hospitalizations in heart failure
, 2001
The role of angiotensin receptor blockers in the magement of chronic heart failure
, 2001
Cardiopulmory exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited
, 2000
The influence of beta-adrenergic blocking drugs on morbidity and mortality in heart failure
, 1999
Spontaneous postpartum corory dissection
, 1999
beta-blockers in heart failure - Do they improve the quality as well as the quantity of life?
, 1998
Neuropeptide Y receptor 1 (NPY-Y1) expression in human heart failure and heart transplantation
, 1998
Angiotensin II receptor subtype AT(1) and AT(2) expression after heart transplantation
, 1998
Use of assumed versus measured oxygen consumption
, 1998
Serial exercise testing and prognosis in selected patients considered for cardiac transplantation
, 1998
Effects of beta blockers on symptoms and functiol capacity in heart failure.
, 1997
Assessment of left ventricular wall motion abnormalities with the use of color kinesis
, 1997
AT(1) and AT(2) angiotensin receptor gene expression in human heart failure
, 1997
Exercise capacity of heart transplant recipients: The importance of chronotropic incompetence
, 1996
Alysis of deaths in patients awaiting heart transplantation: Impact on patient selection criteria
, 1996
Transplant candidates with severe left ventricular dysfunction maged with medical treatment
, 1996
Induction of nitric oxide synthase
, 1996
The relationship of granzyme A and perforin expression to cardiac allograft rejection
, 1995
Selecting candidates for cardiac transplantation
, 1995
Spontaneous reversibility of catecholamine-induced cardiotoxicity in rats.
, 1995
INCIDENCE OF MYOCARDITIS IN PERIPARTUM CARDIOMYOPATHY
, 1994
LONG-TERM OUTCOME AFTER HEART-TRANSPLANTATION FOR PERIPARTUM CARDIOMYOPATHY
, 1994
ABNORMALITIES OF PULMORY-FUNCTION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
, 1994
PROTECTIVE EFFECT OF CLENTIAZEM AGAINST EPINEPHRINE-INDUCED CARDIAC INJURY IN RATS
, 1993
Controlled trials with beta blockers in heart failure: metoprolol as the prototype.
, 1993
Beta-blockers in heart failure: potential of carvedilol.
, 1993
INFLUENCE OF PREOPERATIVE PULMORY-ARTERY PRESSURE ON MORTALITY AFTER HEART
, 1992
The influence of preoperative patient characteristics on early
, 1991
CARDIAC ADRENOCEPTORS IN THE FAILING HEART - EFFECT OF INTERVENTION
, 1990
Selection of patients for cardiac transplantation.
, 1990
HEMODYMIC-EFFECTS OF HIGH-DOSE LOXONE IN CONGESTIVE HEART-FAILURE
, 1989
INCREASED BETA-RECEPTOR DENSITY AND IMPROVED HEMODYMIC
, 1989
HEMODYMIC, REL AND ENDOCRINE EFFECTS OF ATRIAL TRIURETIC PEPTIDE INFUSION IN SEVERE HEART-FAILURE
, 1988
ORTHOTOPIC CARDIAC TRANSPLANTATION FOR UNIVENTRICULAR HEART
, 1988
